QA: Celgene CORP DE in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000816284_2013_Celgene_CORP_DE.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000816284, Celgene CORP DE

  xvar xval
0 AssetsCurrent 5,533,665,000
1 IntangibleAssetsNetIncludingGoodwill 5,143,196,000
2 PropertyPlantAndEquipmentNet 578,362,000
3 remainder_Assets 479,083,000
4 LiabilitiesCurrent 1,690,235,000
5 LiabilitiesNoncurrent 355,546,000
6 remainder_Liabilities 3,994,058,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,373,541,000
9 ResearchAndDevelopmentExpense 1,724,156,000
10 remainder_Expenses 951,090,000
11 remainder_Revenues 5,506,713,000
12 remainder_NetIncome -1,746,000
13 remainder_ComprehensiveNetIncome 12,590,000
  yvar yval
0 Assets 11,734,306,000
1 Liabilities 6,039,839,000
2 Expenses 4,048,787,000
3 Revenues 5,506,713,000
4 StockholdersEquity 5,694,467,000
5 NetIncome 1,456,180,000
6 ComprehensiveNetIncome 1,462,475,000
7 BaseVar 13,671,990,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.56
9 EconomicCapitalRatio 2.72

Edgar->Model Mapping

Feature Distribution

Change over Time